作者
Mensura Sied Filli, Ahmed Abdalla Ibrahim, Md Aquib, Abdul Baset Abbas, Arwa Morshed, Kofi Oti Boakye-Yiadom, Samuel Kesse, Muhammad Asim Farooq, Mily Bazezy, Bo Wang
发表日期
2019
来源
Int. J. Pharm. Sci. Drug Res
卷号
11
页码范围
61-70
简介
Cancer is a leading cause of death throughout the world which suffers from treatment failures mainly due to intensive toxicity and lack of effectiveness of conventional drugs. The application of nanotechnology in cancer treatment promises to overcome the drawbacks of conventional drugs/dosage forms and improve their therapeutic efficacy. Nanomaterials have novel properties that influence their in vivo performance. The biological behaviour of nanotechnology-based medicines in the body, which is different from the in vivo performance of conventional drug delivery systems, may provide benefits in pharmaceutical and/or clinical applications including, enhancements in solubility, stability, therapeutic efficacy, minimized side effects, and treatment of diseases. This paper discusses the unique characteristics and distinguished advantages of nanomaterials as anticancer drug carriers. Physicochemical properties of nanomaterials are critical parameters to their clinical translation. Hence, the impact of the main physicochemical properties on the efficacy of anticancer nanomaterials, which are found to effective for cancer treatment and/or diagnosis, are presented. It is important to have reliable and robust characterization techniques that could enable relate physicochemical properties of nanomaterials with their in vivo behaviour. Brief explanation of the different techniques that can be used for studying the various physicochemical characteristics of nanomaterials is given. An important consideration, to achieve fast and successful development of nanotechnologybased anticancer drug products, is assessment and optimization of physicochemical and …
引用总数
2020202120222023251
学术搜索中的文章